The Human Stress Response in a Simulated ED Setting
NCT04317482 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30
Last updated 2025-10-10
Summary
Stress is important for health. As emergency departments (EDs) are often stressful places, a better understanding of the human stress response is important for understanding how and why patients respond as they do when they come to the ED. Since the investigators cannot take up space in the ED for research, the investigators will instead recruit 20 methamphetamine-using participants who are not currently in treatment and 10 healthy adult matched participants to a simulated ED room in the University of Arkansas for Medical Sciences (UAMS) Simulation Center. The investigators will have participants perform a stressor task involving public speaking and a simple arithmetic task. The investigators will see if this experiment can be made to be like being in an actual ED by varying what participants speak about in the task. By doing this, the investigators hope to find out several important things: 1) Is a stressor task feasible and acceptable to participants? 2) What does the stress response -- as measured by cortisol and alpha-amylase -- look like in these participants? 3) Does varying what participants talk about make the experiment seem more like an actual ED? 4) Do participants under stress show even mild symptoms of agitation as measured by clinical scales? If so, how often?
Conditions
- Stress Physiology
- Stress Reaction
- Substance Use Disorders
- Methamphetamine-dependence
- Stress, Emotional
Interventions
- BEHAVIORAL
-
Standard social stress task
Participants will be asked to respond in detail to three scenarios. This is a standard social stressor task. Participants may be prompted by an experimenter. However, the participant will receive no verbal nor nonverbal feedback.
- BEHAVIORAL
-
Stressful experience in the ED
Participants will be asked to imagine and then describe both feelings and bodily sensations experienced at their most stressful ED visit, in order to help them more fully re-experience the situation. In this regard, the second condition is more similar to stress imagery employed by Sinha et al, which elevated cortisol to a greater degree than a social stressor task. Participants may be prompted by an experimenter. However, the participant will receive no verbal nor nonverbal feedback.
Sponsors & Collaborators
-
University of Arkansas
lead OTHER
Principal Investigators
-
Alison Oliveto, Ph.D. · University of Arkansas
Study Design
- Allocation
- RANDOMIZED
- Purpose
- OTHER
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 21 Years
- Max Age
- 55 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2020-08-26
- Primary Completion
- 2026-12-31
- Completion
- 2026-12-31
Countries
- United States
Study Locations
More Related Trials
-
Effect of Ketamine on Laboratory-induced Stress in Healthy Subjects
NCT04173962 ·Status: COMPLETED ·Phase: PHASE2
-
Methamphetamine and Troriluzole
NCT06989853 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Methamphetamine Isomer Pharmacology in Humans
NCT06746831 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
Why Wait? Initiating Contingency Management in Traumatically Injured Patients During Hospitalization
NCT06931197 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Study of 3,4-Methylenedioxymethamphetamine-assisted Psychotherapy in People With Posttraumatic Stress Disorder
NCT00353938 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of Stimulants on Behavioral and Neural Markers of Social Motivation, Ability, and Neural Markers of Social Function
NCT05379959 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
The Effect of Mindfulness-based Relapse Prevention on Impulsive Control Circuit Among Methamphetamine Dependents
NCT03748875 ·Status: UNKNOWN ·Phase: NA
-
Additional MDMA-assisted Therapy for People Who Relapsed After MDMA-assisted Therapy Trial
NCT01458327 ·Status: COMPLETED ·Phase: PHASE2
-
The Role of Stress Neuromodulators in Decision Making Under Risk and Selective Attention to Threat
NCT04359147 ·Status: COMPLETED ·Phase: NA
-
Effects of Pharmacological Stress and rTMS on Executive Function in Opioid Use Disorder
NCT04231708 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
BXCL501 After Stress to Increase Recovery Success
NCT06943404 ·Status: RECRUITING ·Phase: PHASE2
-
Pharmacological Interaction Between Clonidine and Methylenedioxymethamphetamine (MDMA)
NCT01136278 ·Status: COMPLETED ·Phase: PHASE1
-
Psychological Effects of Methylenedioxymethamphetamine (MDMA) When Administered to Healthy Volunteers (MT-2)
NCT04073433 ·Status: WITHDRAWN ·Phase: PHASE1
-
Evaluation of MDMA on Startle Response
NCT03181763 ·Status: COMPLETED ·Phase: PHASE1
-
Emotional Effects of Methylphenidate and MDMA in Healthy Subjects
NCT01465685 ·Status: COMPLETED ·Phase: PHASE1
-
Marijuana Drug Discrimination and Self-Administration
NCT00943930 ·Status: COMPLETED
-
Acute Dose-dependent Effects of DMT in Healthy Subjects
NCT05384678 ·Status: COMPLETED ·Phase: PHASE1
-
How Stress Alters Opioid Drug Effects
NCT06485817 ·Status: COMPLETED ·Phase: NA
-
Dose-Response Study of MDMA-assisted Psychotherapy in People With PTSD
NCT01793610 ·Status: COMPLETED ·Phase: PHASE2
-
ESM Pilot: Mobile Phones and Psychology
NCT03221985 ·Status: COMPLETED ·Phase: NA
-
Characterizing Drug Liking During Drug Administration in Peri-procedural Clinical Settings
NCT07348172 ·Status: NOT_YET_RECRUITING ·Phase: EARLY_PHASE1
-
Acute Effects of R- and S-MDMA in Healthy Subjects
NCT05277636 ·Status: COMPLETED ·Phase: PHASE1
-
Amantadine for the Treatment of Traumatic Brain Injury Irritability and Aggression: A Multi-site Study
NCT00779324 ·Status: COMPLETED ·Phase: NA
-
Study of the Effects of MDMA/Ecstasy on Water Regulation, Sleep, and Cognition.
NCT01053403 ·Status: COMPLETED ·Phase: NA
-
Apply the PD Model of Peripheral Oxytocin Action to a Multimodal Stimulus
NCT04433741 ·Status: WITHDRAWN ·Phase: PHASE2